The DC Board of Medicine's aesthetic medicine policy classifies neuromodulators (botulinum toxins) and tissue fillers as Level III procedures, which it says are the practice of medicine and may be performed only by persons authorized to practice medicine. Facilities doing these procedures need a medical director physically present at least 50% of operating hours. The board says the policy is directive, not mandatory, until regulations are adopted.
Source: Board of Medicine Policy No. 15-02, Policy on the Practice of Aesthetic Medicine
Board guidance — may not be bindingPublished or effective Nov 13, 2014Checked Sep 14, 2026